BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023)

BioCorRx (BICX) posted Asset Writedowns and Impairment of $47980.0 for Q1 2023, up 1311.18% sequentially from $3400.0 in Q2 2019.

Analysis

BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends

BioCorRx has reported Asset Writedowns and Impairment for 6 years, with the latest figure at $47980.0 in Q1 2023.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $47980.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $47980.0 (changed N/A YoY) and the FY2023 annual result came in at $47980.0, changed N/A from the prior year.
Asset Writedowns and Impairment improved to $47980.0 in Q1 2023 per BICX's latest filing, from $3400.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $47980.0 in Q1 2023 and troughed at -$1000.0 in Q1 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	90.36 Bn	89.35 Bn	15.19 Bn
2	Tenet Healthcare	22.02 Bn	19.85 Bn	4.45 Bn
3	Encompass Health	12.13 Bn	11.99 Bn	1.34 Bn
4	Davita	11.78 Bn	11.09 Bn	1.16 Bn
5	Universal Health Services	10.09 Bn	9.95 Bn	3.29 Bn
6	Ensign	9.97 Bn	9.65 Bn	306.24 Mn
7	Chemed	6.93 Bn	6.89 Bn	221.47 Mn
8	Pacs	6.81 Bn	6.64 Bn	338.46 Mn
9	Concentra Group Holdings Parent	4.32 Bn	4.16 Bn	192.10 Mn
10	BioCorRx	3.46 Mn	3.44 Mn	-

Historic Data

Download Data